COM:VERONAPHARMA
Verona Pharma plc
- Stock
Last Close
29.66
25/09 14:39
Market Cap
1.45B
Beta: -
Volume Today
56.93K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -0.00 - | -0.00 0% | 2.27M 454,537,350,495,622.38% | 4.29M 88.96% | 3.27M 23.78% | 1.25M 61.77% | ||||||
average payables | 432.94K - | 557.20K 28.70% | 1.23M 121.63% | 1.39M 12.81% | 1.26M 9.28% | 2.62M 107.42% | 2.76M 5.10% | 1.04M 62.15% | 5.11M 390.09% | 6.48M 26.73% | 3.20M 50.58% | |
average receivables | 3.55M - | 3.55M 0% | 4.13M 16.24% | 11.92M 188.66% | 12.43M 4.29% | 4.64M 62.67% | ||||||
book value per share | 0.08 - | 0.18 126.71% | 0.07 63.79% | 0.20 209.81% | 9.84 4,745.43% | 6.08 38.24% | 3.37 44.51% | 5.62 66.77% | 2.50 55.51% | 3.90 55.72% | 0.00 99.99% | |
capex per share | -0.00 - | -0.00 23.77% | -0.00 47.01% | -0.00 55.13% | -0.03 3,448.49% | -0.03 3.19% | -0.03 8.51% | -0.00 91.12% | -0.00 91.87% | -0.00 141.67% | ||
capex to depreciation | -2.86 - | -4.16 45.47% | -2.69 35.32% | -2.07 22.97% | -1.76 14.97% | -2.73 55.01% | -0.56 79.54% | -0.13 76.48% | -0.02 85.51% | -0.05 139.01% | ||
capex to operating cash flow | 0.05 - | 0.06 18.92% | 0.02 63.85% | 0.02 1.60% | 0.01 54.17% | 0.01 41.13% | 0.01 43.65% | 0.00 78.18% | 0.00 80.16% | 0.00 34.25% | ||
capex to revenue | -0.16 - | -122.19 76,611.32% | -157.27 28.71% | -0.00 - | -0.06 21,006.26% | |||||||
cash per share | 0.02 - | 0.14 514.19% | 0.04 71.12% | 0.23 466.84% | 9.89 4,117.92% | 6.25 36.81% | 3.06 50.98% | 5.72 86.73% | 2.51 56.14% | 3.85 53.54% | 0.00 99.99% | |
days of inventory on hand | 2.64K - | |||||||||||
days payables outstanding | 3.07K - | |||||||||||
days sales outstanding | 931.96K - | 142.19 - | 7.40K 5,102.18% | |||||||||
debt to assets | 0.01 - | -0.00 100.01% | 0.02 1,873,160.01% | 0.03 38.22% | 0.03 6.88% | 0.04 31.84% | 0.01 76.63% | |||||
debt to equity | 0.01 - | -0.00 100.01% | 0.03 2,115,724.57% | 0.03 14.56% | 0.04 21.98% | 0.05 17.74% | 0.01 74.34% | |||||
dividend yield | ||||||||||||
earnings yield | -0.01 - | -0.00 61.91% | -0.01 108.21% | -0.00 71.67% | -0.28 10,239.37% | -0.25 8.87% | -0.73 188.09% | -0.28 61.25% | -0.14 50.63% | -0.04 68.20% | -0.00 99.99% | |
enterprise value | 346.49M - | 925.32M 167.06% | 1.15B 24.40% | 2.25B 95.56% | 57.03M 97.47% | 74.46M 30.55% | 28.49M 61.74% | 48.03M 68.57% | 254.91M 430.76% | 1.33B 421.12% | 12.61T 948,917.27% | |
enterprise value over ebitda | -75.60 - | -158.96 110.26% | -87.13 45.19% | -245.26 181.50% | -1.44 99.41% | -2.38 64.92% | -0.55 76.89% | -0.74 33.70% | -4.47 507.30% | -21.20 374.39% | -229.87K 1,084,167.33% | |
ev to operating cash flow | -102.27 - | -167.91 64.18% | -122.30 27.16% | -326.51 166.97% | -2.04 99.38% | -3.24 58.88% | -0.64 80.17% | -1.07 65.83% | -7.67 619.44% | -22.19 189.49% | -251.02K 1,131,079.00% | |
ev to sales | 30.98 - | 26.75K 86,260.01% | 12.12K 54.70% | 6.37 - | 2.90K 45,412.84% | |||||||
free cash flow per share | -0.08 - | -0.05 35.29% | -0.08 41.08% | -0.03 55.82% | -2.58 7,549.73% | -1.77 31.11% | -3.40 91.33% | -1.37 59.54% | -0.56 59.07% | -1.01 80.04% | -0.00 99.99% | |
free cash flow yield | -0.01 - | -0.01 39.36% | -0.01 33.75% | -0.00 63.16% | -0.28 9,162.02% | -0.23 17.51% | -0.78 233.05% | -0.20 74.84% | -0.08 57.36% | -0.04 53.70% | -0.00 99.99% | |
graham net net | 0.00 - | 0.14 2,969.24% | 0.02 85.20% | 0.17 724.68% | 8.70 5,153.89% | 5.56 36.11% | 1.94 65.10% | 5.39 177.65% | 2.09 61.25% | 3.50 67.64% | 0.00 99.99% | |
graham number | 0.42 - | 0.40 4.01% | 0.36 10.83% | 0.37 2.60% | 23.65 6,332.55% | 16.21 31.44% | 15.54 4.17% | 15.84 1.94% | 7.27 54.08% | 10.09 38.75% | 0.00 99.99% | |
income quality | 0.73 - | 0.93 27.99% | 0.71 24.14% | 0.94 32.12% | 0.82 12.23% | 0.75 8.61% | 0.86 14.94% | 0.69 19.79% | 0.60 13.51% | 0.87 45.61% | 0.92 6.01% | |
intangibles to total assets | 0.66 - | 0.14 78.51% | 0.25 73.92% | 0.05 79.50% | 0.03 46.39% | 0.03 28.78% | 0.07 104.34% | 0.00 96.23% | 0.00 9.44% | 0.00 28.09% | 0.00 15.79% | |
interest coverage | -82.87 - | -407.62 391.86% | -243.09 - | -2.12K 772.99% | -215.63 89.84% | -126.90 41.15% | 26.66 121.01% | |||||
interest debt per share | 0.00 - | 0.16 31,077.92% | -0.00 100.01% | 0.11 1,382,639.94% | 0.18 63.18% | 0.10 42.89% | 0.19 81.67% | 0.00 100.00% | ||||
inventory turnover | 0.14 - | |||||||||||
invested capital | 0.01 - | -0.00 100.01% | 0.03 2,115,724.57% | 0.03 14.56% | 0.04 21.98% | 0.05 17.74% | 0.01 74.34% | |||||
market cap | 347.48M - | 940.84M 170.76% | 1.16B 22.90% | 2.30B 98.92% | 99.53M 95.67% | 99.56M 0.04% | 57.31M 42.43% | 230.07M 301.41% | 397.48M 72.77% | 1.55B 288.84% | 12.61T 815,579.95% | |
net current asset value | 600.42K - | 16.71M 2,682.33% | 5.57M 66.66% | 39.65M 611.85% | 104.67M 163.99% | 76.56M 26.85% | 38.88M 49.22% | 183.15M 371.07% | 131.48M 28.21% | 213.99M 62.76% | 230.87M 7.88% | |
net debt to ebitda | 0.22 - | 2.67 1,127.06% | 0.40 85.18% | 5.35 1,253.22% | 1.08 79.89% | 0.80 25.36% | 0.56 30.65% | 2.79 400.92% | 2.50 10.39% | 3.47 38.67% | 4.90 41.42% | |
net income per share | -0.10 - | -0.04 59.36% | -0.09 119.62% | -0.03 66.02% | -2.53 8,439.54% | -1.92 23.89% | -3.18 65.50% | -1.98 37.69% | -0.94 52.60% | -1.16 23.63% | -0.00 99.99% | |
operating cash flow per share | -0.08 - | -0.05 35.90% | -0.07 46.57% | -0.03 55.83% | -2.55 7,643.57% | -1.75 31.41% | -3.37 92.56% | -1.37 59.28% | -0.56 59.01% | -1.01 80.01% | -0.00 99.99% | |
payables turnover | 0.12 - | |||||||||||
receivables turnover | 0.00 - | 2.57 - | 0.05 98.08% | |||||||||
research and ddevelopement to revenue | 17.41 - | 8.80K 50,429.72% | 18.67K 112.23% | 1.99 - | 107.60 5,320.49% | |||||||
return on tangible assets | -2.87 - | -0.24 91.46% | -1.33 442.82% | -0.11 91.38% | -0.24 105.52% | -0.28 17.96% | -0.76 174.35% | -0.32 58.00% | -0.30 6.62% | -0.27 11.17% | -0.18 33.38% | |
revenue per share | 0.17 - | 0.00 99.87% | 0.00 15.70% | 0.68 - | 0.01 98.86% | |||||||
roe | -1.22 - | -0.22 82.07% | -1.33 506.57% | -0.15 89.03% | -0.26 76.24% | -0.32 23.24% | -0.94 198.27% | -0.35 62.64% | -0.38 6.54% | -0.30 20.60% | -0.22 26.84% | |
roic | -1.22 - | -0.22 81.95% | -1.33 504.79% | -0.17 87.17% | -0.30 74.43% | -0.34 12.34% | -0.94 179.07% | -0.39 58.59% | -0.47 22.22% | -0.27 42.10% | -0.21 22.32% | |
sales general and administrative to revenue | 4.40 - | 2.87K 65,144.33% | 3.83K 33.34% | |||||||||
shareholders equity per share | 0.08 - | 0.18 126.71% | 0.07 63.79% | 0.20 209.81% | 9.84 4,745.43% | 6.08 38.24% | 3.37 44.51% | 5.62 66.77% | 2.50 55.51% | 3.90 55.72% | 0.00 99.99% | |
stock based compensation to revenue | 2.14 - | 1.32K 61,630.25% | 1.36K 2.92% | 0.64 - | 30.83 4,750.64% | |||||||
tangible asset value | 646.01K - | 16.74M 2,491.24% | 5.59M 66.60% | 39.67M 609.55% | 104.69M 163.93% | 76.59M 26.84% | 40.21M 47.50% | 184.31M 358.37% | 147.46M 19.99% | 229.92M 55.92% | 248.74M 8.18% | |
tangible book value per share | 0.02 - | 0.15 921.15% | 0.04 71.34% | 0.19 327.82% | 9.55 4,938.00% | 5.83 38.93% | 3.05 47.61% | 5.61 83.62% | 2.49 55.54% | 3.89 55.92% | 0.00 99.99% | |
working capital | 600.42K - | 16.71M 2,682.33% | 5.57M 66.66% | 40.64M 629.62% | 106.06M 160.97% | 77.96M 26.49% | 41.05M 47.35% | 188.30M 358.73% | 136.64M 27.43% | 223.97M 63.91% | 281.02M 25.47% |
All numbers in (except ratios and percentages)